ThermoGenesis Holdings(THMO) - 2019 Q3 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q X Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2019. or ___ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition from _____________ to _______________. Commission File Number: 000-16375 ThermoGenesis Holdings, Inc. (formerly known as Cesca Therapeutics Inc.) (Exact name ...